
Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proe... Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body's primary defense against cancer. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.71 | -51.619047619 | 5.25 | 8.28 | 1.25 | 942 | 5.97319533 | CS |
4 | -4.21 | -62.3703703704 | 6.75 | 8.28 | 1.25 | 810 | 5.76494885 | CS |
12 | -15.46 | -85.8888888889 | 18 | 18 | 1.25 | 4168386 | 14.01855849 | CS |
26 | -15.46 | -85.8888888889 | 18 | 24 | 1.25 | 6647382 | 18.9816384 | CS |
52 | -117.46 | -97.8833333333 | 120 | 222 | 1.25 | 14508344 | 55.58344802 | CS |
156 | 1699.54204219 | -100.149675719 | -1697.00204219 | 15750 | -1509.16593828 | 21556236 | -91.42385434 | CS |
260 | 2399.06960156 | -100.10598659 | -2396.52960156 | 15750 | -2072.67425 | 15159119 | -213.1687772 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관